-
- 小林 江梨子
- 千葉大学大学院薬学研究院臨床教育
-
- 浅田 和広
- 日本製薬工業協会医薬品評価委員会 PMS 部会
-
- 阿部 智美
- 千葉大学大学院薬学研究院臨床教育
-
- 荒田 尚子
- 国立成育医療研究センター周産期・母性診療センター
-
- 大山 邦男
- 東京薬科大学薬学教育推進センター
-
- 川上 明三
- 昭和大学病院
-
- 工藤 賢三
- 岩手医科大学薬学部臨床薬剤学講座
-
- 小村 誠
- 国立成育医療研究センター薬剤部
-
- 島田 安博
- 国立がん研究センター中央病院消化管内科
-
- 鳥山 五月
- 日本製薬工業協会医薬品評価委員会 PMS 部会
-
- 服部 洋子
- 日本製薬工業協会医薬品評価委員会 PMS 部会
-
- 宮村 充彦
- 高知大学医学部附属病院
-
- 村島 温子
- 国立成育医療研究センター周産期・母性診療センター
-
- 村山 純一郎
- 昭和大学病院 昭和大学薬学部病院薬剤学講座
-
- 佐藤 信範
- 千葉大学大学院薬学研究院臨床教育
書誌事項
- タイトル別名
-
- <b>A Proposal of New Prescription Drug Labeling </b>
この論文をさがす
抄録
Prescription drug labeling currently used in clinical practice is legally required drug information, and is regulated by the MHLW notification entitled “Guidance to describe prescription drug labeling” issued in 1997. Previous research has revealed that the majority of physicians and pharmacists, who are real users of the drug labeling, acknowledged the importance of drug labeling and recognized that the order of description in the labeling is appropriate. However, over a half of them did not recognize that “conditions for approval” are described in the labeling. The aim of the present study was to develop new format and contents of prescription drug labeling and to verify the new labeling by a large-scale questionnaire survey on physicians and pharmacists who work in clinical practice. New format and contents of prescription drug labeling were created to solve the problems indicated by previous studies. The questionnaire was distributed by post to 2,004 physicians and pharmacists to verify the new format and contents of prescription drug labeling, and 1,100 questionnaires were returned (response rate: 54.9%). Over 85% of respondents agreed to number all the items in drug labeling. Over 84% of them agreed to group the information of patients included in “administration with caution”, “pediatrics”, “pregnant and lactating women” and “elderly” into a single item of “information on special populations”. Regarding the newly created item “information on medical insurance coverage”, the majority of the respondents (over 96%) agreed. The proposed new format and contents of prescription drug labeling were verified and supported by physicians and pharmacists. Further activities are needed to distribute the proposed new format and contents of prescription drug labeling to a wide range of medical professionals to collect more opinions.
収録刊行物
-
- 臨床薬理
-
臨床薬理 46 (2), 55-63, 2015
一般社団法人 日本臨床薬理学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001205368093696
-
- NII論文ID
- 130005064870
-
- ISSN
- 18828272
- 03881601
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可